Evodol

CAS No.:22318-10-1

TB00558
11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,14a-octahydro-3-hydroxy-2,2,4a,8a-tetramethyl-,(4aR,4bR,5aS,8S,8aS,10aR,10bR,14aS)-;Evodol(7CI);Limonin diosphenol (6CI);Limonoic acid, 5,6-didehydro-6-hydroxy-, di-d-lactone;11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,14a-octahydro-3-hydroxy-2,2,4a,8a-tetramethyl-,[4aR-(4aa,4bR*,5ab,8b,8ab,10ab,10bR*,14ab)]-;Glaucin C;NSC 314322;Evodol;[(3S,8S,9S,10R,13S,14S,16R,17R)-17-acetyl-16-(aziridin-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(...;11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,;11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,14a-octahydro-3-hydroxy-2,2,4a,8a-tetramethyl-,(4aR,4bR,5aS,8S,8aS,10aR,10b;[ "" ];(1S,2R,7S,13R,14S,16R,19R,20R)-19-(Furan-3-yl)-11-hydroxy-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahe;LIMONIN DIOSPHENOL;C26H28O9;XL1618
inquiry
C26H28O9
484.50

Product introduction

Category: Triterpenoids
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: O1[C@]2([H])C(=O)O[C@@]([H])(C3=C([H])OC([H])=C3[H])[C@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]4([H])[C@@]56C([H])([H])OC(C([H])([H])[C@]5([H])OC(C([H])([H])[H])(C([H])([H])[H])C6=C(C([C@@]4(C([H])([H])[H])[C@]132)=O)O[H])=O